Halperin JL - Search Results

1

Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF study.

Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Ziegler PD, Kaplon RE, Sherfesee L, Wachter R; REVEAL AF Investigators. Reiffel JA, et al. Among authors: halperin jl. Am Heart J. 2020 Jan;219:128-136. doi: 10.1016/j.ahj.2019.07.016. Am Heart J. 2020. PMID: 31862084

2

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Flaker GC, et al. Among authors: halperin jl. J Am Coll Cardiol. 1992 Sep;20(3):527-32. doi: 10.1016/0735-1097(92)90003-6. J Am Coll Cardiol. 1992. PMID: 1512329 Free article. Clinical Trial.

3

Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Flaker GC, et al. Among authors: halperin jl. Am J Cardiol. 1995 Aug 15;76(5):355-8. doi: 10.1016/s0002-9149(99)80100-3. Am J Cardiol. 1995. PMID: 7639159

4

Stroke prevention in atrial fibrillation.

Halperin JL, Rothlauf EB. Halperin JL, et al. Mt Sinai J Med. 1993 Sep;60(4):289-94. Mt Sinai J Med. 1993. PMID: 8232372 Review.

5

Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators.

Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, Pennock GD, Safford RE, Rothbart RM, Halperin JL, Hart RG. Dittrich HC, et al. Among authors: halperin jl. Am Heart J. 1999 Mar;137(3):494-9. doi: 10.1016/s0002-8703(99)70498-9. Am Heart J. 1999. PMID: 10047632 Clinical Trial.

6

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

Halperin JL; Executive Steering Committee, SPORTIF III and V Study Investigators. Halperin JL, et al. Am Heart J. 2003 Sep;146(3):431-8. doi: 10.1016/S0002-8703(03)00325-9. Am Heart J. 2003. PMID: 12947359 Clinical Trial.

7

Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.

Halperin JL. Halperin JL. J Am Coll Cardiol. 2005 Jan 4;45(1):1-9. doi: 10.1016/j.jacc.2004.09.049. J Am Coll Cardiol. 2005. PMID: 15629364 Free article.

8

Anticoagulation for atrial fibrillation in the elderly.

Halperin JL. Halperin JL. Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):81-6. doi: 10.1111/j.1076-7460.2005.02282.x. Am J Geriatr Cardiol. 2005. PMID: 15785149 Review.

9

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL. Olsson SB, et al. Among authors: halperin jl. Semin Vasc Med. 2005 Aug;5(3):285-92. doi: 10.1055/s-2005-916168. Semin Vasc Med. 2005. PMID: 16123916 Review.

10

Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.

Klein AL, Grimm RA, Jasper SE, Murray RD, Apperson-Hansen C, Lieber EA, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF; ACUTE Steering and Publications Committee for the ACUTE Investigators. Klein AL, et al. Among authors: halperin jl. Am Heart J. 2006 Feb;151(2):380-9. doi: 10.1016/j.ahj.2005.07.011. Am Heart J. 2006. PMID: 16442904 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters